Search by Drug Name or NDC
NDC 00338-1709-40 MAGNESIUM SULFATE IN DEXTROSE 10 mg/mL Details
MAGNESIUM SULFATE IN DEXTROSE 10 mg/mL
MAGNESIUM SULFATE IN DEXTROSE is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is MAGNESIUM SULFATE HEPTAHYDRATE.
Product Information
| NDC | 00338-1709 |
|---|---|
| Product ID | 0338-1709_f21cee72-13a2-41e9-9410-3d6a1262a072 |
| Associated GPIs | 79400010412032 |
| GCN Sequence Number | 063498 |
| GCN Sequence Number Description | magnesium sulfate/D5W PIGGYBACK 1 G/100 ML INTRAVEN |
| HIC3 | C1H |
| HIC3 Description | MAGNESIUM SALTS REPLACEMENT |
| GCN | 99224 |
| HICL Sequence Number | 006306 |
| HICL Sequence Number Description | MAGNESIUM SULFATE/DEXTROSE 5 % IN WATER |
| Brand/Generic | Generic |
| Proprietary Name | MAGNESIUM SULFATE IN DEXTROSE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | magnesium sulfate in dextrose |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/mL |
| Substance Name | MAGNESIUM SULFATE HEPTAHYDRATE |
| Labeler Name | Baxter Healthcare Corporation |
| Pharmaceutical Class | Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA211965 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00338-1709-40 (00338170940)
| NDC Package Code | 0338-1709-40 |
|---|---|
| Billing NDC | 00338170940 |
| Package | 40 BAG in 1 CASE (0338-1709-40) / 100 mL in 1 BAG |
| Marketing Start Date | 2020-08-11 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |